Variability of haptoglobin beta-chain proteoforms
-
Published:2024
Issue:2
Volume:70
Page:114-124
-
ISSN:2310-6905
-
Container-title:Biomeditsinskaya Khimiya
-
language:ru
-
Short-container-title:BIOMED KHIM
Author:
Ronzhina N.L.1, Zorina E.S.2, Zavialova M.G.2, Legina O.K.1, Naryzhny S.N.1
Affiliation:
1. B.P. Konstantinov Petersburg Institute of Nuclear Physics, National Research Center “Kurchatov Institute”, Gatchina, Leningrad Region, Russia 2. Institute of Biomedical Chemistry, Moscow, Russia
Abstract
Existing knowledge on changes of the haptoglobin (Hp) molecule suggests that it may exist in multiple proteoforms, which obviously exhibit different functions. Using two-dimensional electrophoresis (2DE) in combination with mass spectrometry and immunodetection, we have analyzed blood plasma samples from both healthy donors and patients with primary grade IV glioblastoma (GBM), and obtained a detailed composite 2DE distribution map of β-chain proteoforms, as well as the full-length form of Hp (zonulin). Although the total level of plasma Hp exceeded normal values in cancer patients (especially patients with GBM), the presence of particuar proteoforms, detected by their position on the 2DE map, was very individual. Variability was found in both zonulin and the Hp β-chain. The presence of an alkaline form of zonulin in plasma can be considered a conditional, but insufficient, GBM biomarker. In other words, we found that at the level of minor proteoforms of Hp, even in normal conditions, there was a high individual variability. On the one hand, this raises questions about the reasons for such variability, if it is present not only in Hp, but also in other proteins. On the other hand, this may explain the discrepancy between the number of experimentally detected proteoforms and the theoretically possible ones not only in Hp, but also in other proteins.
Publisher
Institute of Biochemistry
Reference33 articles.
1. Zhang S., Shang S., Li W., Qin X., Liu Y. (2016) Insights on N-glycosylation of human haptoglobin and its association with cancers. Glycobiology, 26(7), 684-692. 2. Kumar D.M., Thota B., Shinde S.V., Prasanna K.V., Hegde A.S., Arivazhagan A., Chandramouli B.A., Santosh V., Somasundaram K. (2010) Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: Implications in cancer cell migration and tumor growth. J. Proteome Res., 9(11), 5557-5567. 3. Gollapalli K., Ray S., Srivastava R., Renu D., Singh P., Dhali S., Bajpai Dikshit J., Srikanth R., Moiyadi A., Srivastava S. (2012) Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics, 12(14), 2378-2390. 4. Garibay-Cerdenares O.L., Hernández-Ramírez V.I., Osorio-Trujillo J.C., Hernández-Ortíz M., Gallardo-Rincón D., Cantú de León D., Encarnación-Guevara S., Villegas-Pineda J.C., Talamás-Rohana P. (2014) Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients. J. Ovarian Res., 7(1), 27. 5. Ye B., Cramer D.W., Skates S.J., Gygi S.P., Pratomo V., Fu L., Horick N.K., Licklider L.J., Schorge J.O., Berkowitz R.S., Mok S.C. (2003) Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry. Clin. Cancer Res., 9(8), 2904-2911.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|